Clinical Approach to Myoclonus
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of myoclonus
Myoclonus is one of the most commonly encountered movement disorders in clinical practice, affecting approximately 8.6 per 100,000 persons annually. It accounts for up to 3% of all referrals to specialized movement disorder clinics. While often benign—nearly everyone has experienced hypnic jerks when falling asleep—myoclonus can also herald serious underlying neurological disease, including progressive neurodegenerative conditions, metabolic encephalopathies, and post-anoxic brain injury. The clinical challenge lies in distinguishing benign from pathological forms and identifying the underlying etiology to guide appropriate management.
Definition
Myoclonus is defined as a sudden, brief, shock-like involuntary movement caused by muscular contractions (positive myoclonus) or inhibitions (negative myoclonus or asterixis). The jerks are typically less than 100 milliseconds in duration, distinguishing them from other hyperkinetic movement disorders. Myoclonus can arise from dysfunction at any level of the nervous system—from the cerebral cortex to the spinal cord and even peripheral nerves.
Classification by Etiology
The most clinically useful classification system categorizes myoclonus by its underlying cause, as this directly impacts investigation and management strategies.
| Category | Description | Common Examples | Clinical Significance |
|---|---|---|---|
| Physiological | Normal myoclonus in healthy individuals | Hypnic jerks, hiccups, exercise-induced jerks | Benign; no workup needed if isolated and typical |
| Essential | Myoclonus as the sole or predominant neurological abnormality | Essential myoclonus, hereditary myoclonus-dystonia | Often familial; may respond to alcohol; workup to exclude other causes |
| Epileptic | Myoclonus occurring as part of an epilepsy syndrome | Juvenile myoclonic epilepsy, progressive myoclonic epilepsies | Requires electroencephalogram; antiseizure medication indicated |
| Symptomatic (Secondary) | Myoclonus secondary to an identifiable underlying condition | Post-hypoxic, metabolic, toxic, neurodegenerative | Most common category; treat underlying cause when possible |
Classification by Anatomical Origin
Determining the neuroanatomical origin of myoclonus is essential for both diagnosis and treatment selection, as different generators respond to different therapies.
Cortical Myoclonus
Origin: Sensorimotor cortex
Features: Focal or multifocal, stimulus-sensitive, often action-induced. Associated with giant somatosensory evoked potentials and cortical correlate on electroencephalogram back-averaging.
Implications: Most common pathological type; responds to levetiracetam, valproate, piracetam
Subcortical Myoclonus
Origin: Brainstem (reticular formation) or basal ganglia
Features: Generalized, often with prominent axial involvement. Reticular reflex myoclonus shows characteristic rostral-to-caudal spread.
Implications: Commonly seen in post-hypoxic myoclonus; may respond to clonazepam
Spinal Myoclonus
Origin: Spinal cord segments
Features: Segmental or propriospinal distribution. Propriospinal myoclonus causes truncal flexion jerks, often worse when supine.
Implications: Investigate for structural spinal lesions; functional cases common
Peripheral Myoclonus
Origin: Peripheral nerve, plexus, or nerve root
Features: Restricted to distribution of affected nerve; may be rhythmic (hemifacial spasm is a classic example).
Implications: Investigate for compressive or irritative lesions; may respond to botulinum toxin
Classification by Clinical Features
| Feature | Types | Clinical Significance |
|---|---|---|
| Distribution | Focal, segmental, multifocal, generalized | Focal suggests cortical or peripheral origin; generalized suggests subcortical or metabolic cause |
| Temporal Pattern | Sporadic (irregular), rhythmic, oscillatory | Rhythmic myoclonus may be spinal or brainstem in origin; oscillatory suggests tremor overlap |
| Relationship to Movement | Rest, action, intention, stimulus-sensitive | Action myoclonus suggests cortical origin; stimulus-sensitivity suggests reflex myoclonus |
| Polarity | Positive (muscle contraction) or negative (asterixis) | Negative myoclonus (asterixis) classically associated with metabolic encephalopathy |
Classification by Time Course
| Category | Duration | Common Causes | Clinical Approach |
|---|---|---|---|
| Acute | Hours to days | Toxic or metabolic encephalopathy, drug-induced, acute hypoxic injury, Creutzfeldt-Jakob disease | Urgent workup; often requires hospitalization; identify and treat underlying cause |
| Subacute | Weeks to months | Autoimmune encephalitis, paraneoplastic syndromes, subacute sclerosing panencephalitis, prion disease | Comprehensive workup including autoimmune and paraneoplastic panels; consider brain biopsy |
| Chronic Progressive | Months to years, worsening | Progressive myoclonic epilepsies, neurodegenerative diseases, storage disorders | Genetic testing often indicated; multidisciplinary care; symptomatic management |
| Chronic Static | Months to years, stable | Essential myoclonus, post-hypoxic Lance-Adams syndrome, structural lesions | Focus on symptomatic treatment; rehabilitation important |
Key Concept: The Three Questions
When evaluating any patient with myoclonus, systematically answer three fundamental questions:
- Where is it coming from? — Determine the anatomical generator (cortical, subcortical, spinal, peripheral)
- What is causing it? — Identify the underlying etiology (physiological, essential, epileptic, or symptomatic)
- How disabling is it? — Assess functional impact to guide treatment intensity
2. Pathophysiology and Mechanisms
Understanding the neurophysiological basis of myoclonus
Myoclonus results from abnormal neuronal excitability at various levels of the nervous system. Understanding the underlying mechanisms is crucial because the anatomical generator determines both the clinical presentation and the optimal treatment approach. The key pathophysiological principle is an imbalance between excitatory and inhibitory neurotransmission, leading to hypersynchronous neuronal discharges that manifest as sudden muscle jerks.
Neural Generators of Myoclonus
| Generator | Anatomical Structure | Mechanism | Neurophysiological Signature |
|---|---|---|---|
| Cortical | Primary sensorimotor cortex | Hyperexcitable cortical neurons generate brief discharges that propagate down corticospinal tract | Giant somatosensory evoked potentials; cortical spike preceding electromyography burst by 20-40 milliseconds on back-averaging |
| Cortical-Subcortical | Thalamocortical circuits | Abnormal oscillatory activity in thalamocortical loops; often associated with epilepsy syndromes | Generalized spike-wave discharges on electroencephalogram; bilateral synchronous jerks |
| Brainstem (Reticular) | Reticular formation of medulla | Hyperexcitable brainstem neurons cause generalized activation via reticulospinal tract | Short electromyography burst duration; rostral-to-caudal recruitment pattern; no cortical correlate |
| Spinal | Spinal cord gray matter | Loss of inhibitory interneuron function or structural lesion causing segmental hyperexcitability | Segmental distribution; slow propriospinal spread; may be stimulus-sensitive |
| Peripheral | Peripheral nerve, root, or plexus | Ectopic impulse generation or ephaptic transmission at sites of nerve injury or compression | Distribution limited to single nerve territory; rhythmic firing pattern |
Cortical Myoclonus: The Most Common Pathological Type
Generation
Site: Primary sensorimotor cortex (area 4 and area 3b)
Mechanism: Loss of intracortical inhibition allows hyperexcitable pyramidal neurons to discharge synchronously
Propagation: Corticospinal tract activation produces brief muscle contraction in somatotopic distribution
Clinical Features
Distribution: Focal or multifocal, often distal predominant
Triggers: Highly stimulus-sensitive (touch, sound, movement)
Action sensitivity: Characteristically worse with voluntary movement (action myoclonus)
Neurophysiology
Somatosensory evoked potentials: Giant P25-N33 complex (amplitude greater than 10 microvolts)
Electroencephalogram back-averaging: Cortical spike 20-40 milliseconds before electromyography onset
C-reflex: Enhanced long-latency reflex on electromyography
Reticular Reflex Myoclonus
Reticular reflex myoclonus originates in the brainstem reticular formation and produces generalized jerks through activation of the reticulospinal tract. This is the mechanism underlying post-hypoxic myoclonus (Lance-Adams syndrome) and certain toxic-metabolic encephalopathies.
| Feature | Reticular Myoclonus | Cortical Myoclonus |
|---|---|---|
| Distribution | Generalized, prominent axial and proximal involvement | Focal or multifocal, often distal predominant |
| Spread pattern | Rostral-to-caudal (brainstem activates cranial nerves, then spreads caudally) | Somatotopic spread from cortical focus |
| Electromyography burst | Shorter duration (10-30 milliseconds) | Longer duration (50-100 milliseconds) |
| Electroencephalogram correlate | Absent or follows electromyography burst | Precedes electromyography burst by 20-40 milliseconds |
| Somatosensory evoked potentials | Normal or reduced | Giant responses |
Neurotransmitter Systems Involved
Inhibitory Systems (Deficient)
GABA (gamma-aminobutyric acid): Primary inhibitory neurotransmitter; reduced GABAergic tone is central to most myoclonus. Explains efficacy of benzodiazepines (enhance GABA-A) and valproate (multiple GABA mechanisms).
Glycine: Major inhibitory transmitter in spinal cord and brainstem; glycine receptor dysfunction causes hyperekplexia (startle disease).
Serotonin (5-HT): Modulates brainstem excitability; post-hypoxic myoclonus may involve serotonergic dysfunction; 5-hydroxytryptophan sometimes beneficial.
Excitatory Systems (Enhanced)
Glutamate: Primary excitatory neurotransmitter; enhanced glutamatergic transmission in cortex and brainstem contributes to hyperexcitability. Levetiracetam may modulate glutamate release.
Norepinephrine: Increased noradrenergic activity may enhance reticular formation excitability in post-hypoxic states.
Acetylcholine: Cholinergic enhancement worsens myoclonus in some conditions; anticholinesterases can precipitate jerks.
Mechanisms by Specific Conditions
| Condition | Primary Mechanism | Treatment Implication |
|---|---|---|
| Post-hypoxic myoclonus (Lance-Adams syndrome) | Selective loss of inhibitory interneurons in cortex and brainstem; serotonergic dysfunction in reticular formation | Levetiracetam, valproate, clonazepam; consider 5-hydroxytryptophan; often requires polytherapy |
| Juvenile myoclonic epilepsy | Thalamocortical hyperexcitability with abnormal oscillations; genetic channelopathies affecting neuronal excitability | Valproate, levetiracetam, lamotrigine; avoid carbamazepine, phenytoin (may worsen) |
| Progressive myoclonic epilepsies | Neuronal storage or degeneration affecting inhibitory circuits; specific mechanism varies by underlying disorder | Symptomatic treatment; valproate, clonazepam; avoid phenytoin; disease-specific therapy when available |
| Creutzfeldt-Jakob disease | Spongiform degeneration disrupts cortical and subcortical networks; loss of inhibitory interneurons | Symptomatic only; clonazepam, valproate may provide temporary benefit |
| Uremic encephalopathy | Accumulation of uremic toxins impairs GABAergic transmission; parathyroid hormone affects neuronal excitability | Dialysis; correct metabolic abnormalities; symptomatic treatment with clonazepam |
| Hepatic encephalopathy | Ammonia toxicity affects astrocyte function and alters neurotransmission; classic cause of asterixis | Treat hepatic failure; lactulose, rifaximin; correct precipitants |
| Myoclonus-dystonia syndrome | Mutations in SGCE gene (epsilon-sarcoglycan) affect basal ganglia-cerebellar circuits; alcohol-responsive | Alcohol transiently effective; clonazepam; deep brain stimulation of globus pallidus internus in severe cases |
| Serotonin syndrome | Excessive serotonergic activity, particularly 5-HT1A and 5-HT2A receptor activation in brainstem and spinal cord | Stop offending agents; supportive care; cyproheptadine (serotonin antagonist) in severe cases |
Negative Myoclonus (Asterixis)
Asterixis represents sudden, brief lapses of sustained posture due to transient interruption of muscle activity—the opposite of positive myoclonus. Understanding this mechanism is clinically important because asterixis is the hallmark of metabolic encephalopathy.
| Feature | Description |
|---|---|
| Mechanism | Brief (50-200 milliseconds) involuntary silencing of muscles maintaining posture; caused by transient inhibition of tonic motor neuron activity |
| Generator | Usually subcortical (thalamus, brainstem reticular formation); can be cortical in focal structural lesions |
| Classic presentation | Flapping tremor of outstretched hands; actually represents irregular lapses in wrist extension rather than true tremor |
| Common causes | Hepatic encephalopathy, uremia, hypercapnia, drug toxicity (especially anticonvulsants, lithium), focal thalamic lesions |
Often Overlooked Mechanism: Propriospinal Myoclonus
Propriospinal myoclonus arises from spinal cord generators and produces characteristic axial jerks causing truncal flexion (or extension). The myoclonus spreads slowly up and down the cord via propriospinal pathways, creating a distinctive pattern where proximal muscles activate before distal ones. Importantly, functional (psychogenic) propriospinal myoclonus is common and can be distinguished by variable latency, distractibility, and absence of consistent electromyography recruitment pattern. Always consider functional etiology in patients with propriospinal-type jerks, especially when symptoms are inconsistent or worsen with attention.
3. History Taking
A comprehensive approach to eliciting the myoclonus history
Red Flags — Require Urgent Evaluation
- Acute onset with altered consciousness — Metabolic emergency, toxic exposure, or status epilepticus
- Recent cardiac arrest or hypoxic event — Post-hypoxic myoclonus; prognostic implications
- Rapidly progressive cognitive decline — Creutzfeldt-Jakob disease, autoimmune encephalitis
- Associated fever or meningismus — Infectious encephalitis
- New-onset seizures with myoclonus — Progressive myoclonic epilepsy, new epilepsy syndrome
- Recent medication changes — Serotonin syndrome, neuroleptic malignant syndrome, drug toxicity
- Associated ataxia and cognitive decline — Progressive myoclonic ataxia, prion disease
- Known malignancy — Paraneoplastic syndrome (anti-Yo, anti-Hu, anti-NMDA receptor)
Systematic History: The “JERKS” Approach
Use the mnemonic “JERKS” to ensure comprehensive history taking for myoclonus:
- J — Jerk characteristics: What do the movements look like? Are they brief shock-like jerks or slower movements? Single or repetitive? Which body parts are affected?
- E — Evolution and timing: When did it start? Sudden or gradual onset? Is it getting worse, better, or stable? Constant or intermittent throughout the day?
- R — Relationship to activity: Does it occur at rest, with action, or both? Is it worse with specific movements or positions? Does it occur during sleep?
- K — Kick-starters (triggers): What provokes the jerks? Sound, touch, light, movement, startle? Does anything make it better (alcohol, sleep, relaxation)?
- S — Surrounding symptoms: Any seizures, cognitive changes, balance problems, weakness, sensory changes, or psychiatric symptoms?
Characterizing the Myoclonus
| Feature to Assess | Questions to Ask | Clinical Significance |
|---|---|---|
| Distribution | “Which parts of your body jerk? Is it always the same part or does it move around? Does it affect both sides equally?” | Focal suggests cortical or peripheral origin; generalized suggests subcortical or metabolic; multifocal suggests cortical myoclonus |
| Timing pattern | “Are the jerks regular like a rhythm, or random and unpredictable? How often do they occur?” | Rhythmic suggests spinal or brainstem origin; irregular suggests cortical; very rhythmic may be tremor misdiagnosed as myoclonus |
| Relationship to movement | “Do the jerks happen when you’re still, when you move, or both? Are they worse when you try to do something precise?” | Action myoclonus suggests cortical origin; rest myoclonus may be subcortical; intention worsening suggests cerebellar involvement |
| Stimulus sensitivity | “Do sudden sounds, touches, or lights trigger the jerks? Does tapping on a muscle cause it to jerk?” | Stimulus-sensitive myoclonus suggests cortical reflex myoclonus or hyperekplexia; implies specific testing needed |
| Sleep relationship | “Do the jerks happen as you fall asleep? Do they wake you up? Do they continue during sleep?” | Hypnic jerks are physiological; persistence in sleep suggests organic cause; disappearance in sleep may suggest functional etiology |
| Suppressibility | “Can you stop or reduce the jerks by concentrating or relaxing? Does distraction help?” | Highly suppressible or variable with attention suggests functional myoclonus; organic myoclonus typically not volitionally controlled |
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Post-hypoxic myoclonus (Lance-Adams syndrome) | History of cardiac arrest, near-drowning, or respiratory failure; action-induced jerks | “Have you ever had a cardiac arrest, stopped breathing, or been resuscitated? When did the jerks start relative to that event?” |
| Juvenile myoclonic epilepsy | Morning jerks, generalized tonic-clonic seizures, teenage onset, sleep deprivation trigger | “Do you have jerks mainly in the morning after waking? Have you ever had a convulsive seizure? Does lack of sleep make it worse?” |
| Myoclonus-dystonia syndrome | Family history, alcohol responsiveness, associated dystonia, young onset | “Does alcohol dramatically improve your jerks? Does anyone else in your family have similar movements or tremor? Do you have any twisting postures?” |
| Progressive myoclonic epilepsy | Progressive course, cognitive decline, ataxia, seizures, consanguinity | “Is your balance getting worse over time? Have you noticed any memory or thinking problems? Are your parents related to each other?” |
| Creutzfeldt-Jakob disease | Rapidly progressive dementia, visual symptoms, ataxia, characteristic periodic electroencephalogram | “How quickly have the symptoms developed? Any problems with vision? Any difficulty walking? Any family history of early dementia?” |
| Metabolic encephalopathy | Known liver or kidney disease, fluctuating consciousness, asterixis | “Do you have liver or kidney problems? Has your consciousness been fluctuating? Do your hands flap when held outstretched?” |
| Autoimmune or paraneoplastic | Subacute onset, psychiatric symptoms, autonomic instability, known cancer | “Have you had any psychiatric symptoms, confusion, or personality changes? Any unexplained weight loss? Any history of cancer?” |
| Functional (psychogenic) myoclonus | Variable, distractible, incongruent features, psychological stressors | “Do the jerks change when you’re distracted or focused on something else? Have you experienced significant stress or trauma recently?” |
Medication and Substance History
Medications That Cause Myoclonus
- Opioids — Especially with high doses or renal impairment; morphine metabolites particularly problematic
- Antidepressants — Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors (serotonin syndrome risk)
- Antipsychotics — Tardive myoclonus; also in neuroleptic malignant syndrome
- Anticonvulsants — Carbamazepine, phenytoin, gabapentin, pregabalin (paradoxically can cause or worsen myoclonus)
- Antibiotics — Quinolones, cephalosporins, penicillins (especially with renal failure)
- Lithium — Especially at toxic levels; also causes asterixis
- Dopaminergic agents — Levodopa, dopamine agonists in Parkinson disease
- Anesthetic agents — Etomidate, propofol, ketamine
- Contrast media — Particularly with intrathecal administration
Substances and Toxins
- Alcohol — Withdrawal causes myoclonus; chronic use may cause cerebellar myoclonus; note alcohol improves myoclonus-dystonia
- Recreational drugs — Cocaine, amphetamines, methylenedioxymethamphetamine (ecstasy), synthetic cannabinoids
- Heavy metals — Bismuth, mercury, manganese
- Organophosphates — Occupational or intentional exposure
Drug Withdrawal
- Benzodiazepines — Withdrawal myoclonus common
- Barbiturates — Withdrawal can cause myoclonus and seizures
- Baclofen — Abrupt withdrawal causes severe myoclonus
Past Medical History Checklist
| Category | Conditions to Ask About | Relevance |
|---|---|---|
| Hypoxic events | Cardiac arrest, near-drowning, respiratory failure, carbon monoxide poisoning, anesthesia complications | Post-hypoxic myoclonus (Lance-Adams syndrome); delayed onset possible |
| Epilepsy | Known epilepsy, childhood seizures, febrile seizures, family history of epilepsy | Myoclonus may be part of epilepsy syndrome; affects medication choice |
| Metabolic disease | Liver cirrhosis, chronic kidney disease, thyroid disorders, diabetes | Metabolic encephalopathy; uremia; hepatic encephalopathy; hypoglycemia |
| Malignancy | Any cancer, especially lung, ovarian, breast, lymphoma | Paraneoplastic syndromes (opsoclonus-myoclonus, limbic encephalitis) |
| Autoimmune disease | Systemic lupus erythematosus, celiac disease, thyroiditis, other autoimmune conditions | Autoimmune encephalitis more likely; celiac disease associated with cortical myoclonus |
| Neurodegenerative disease | Parkinson disease, dementia with Lewy bodies, Alzheimer disease, multiple system atrophy | Myoclonus can occur in later stages of many neurodegenerative conditions |
Family History
Key Family History Questions
A detailed family history is essential as many causes of myoclonus are hereditary:
- Similar movements in relatives? — Essential myoclonus and myoclonus-dystonia are often familial
- Epilepsy in family? — Genetic epilepsy syndromes including juvenile myoclonic epilepsy
- Early-onset dementia? — Familial Creutzfeldt-Jakob disease, familial Alzheimer disease, Huntington disease
- Consanguinity? — Increases risk of autosomal recessive conditions (progressive myoclonic epilepsies, storage disorders)
- Movement disorders? — Dystonia, tremor, Parkinson disease may be related
- Unexplained neurological disease? — May represent undiagnosed hereditary condition
4. Physical Examination
A systematic neurological approach for evaluating myoclonus
Systematic Framework: Use the “Observe, Activate, Examine” approach for complete evaluation of patients presenting with myoclonus. First observe the patient at rest and during conversation, then use specific activation maneuvers to elicit myoclonus, and finally perform a comprehensive neurological examination to identify associated findings that help localize the generator and identify the underlying cause.
General Inspection
- Level of consciousness: Altered awareness suggests metabolic, toxic, or infectious encephalopathy; fully alert in essential myoclonus and most epileptic myoclonus
- Spontaneous jerks: Observe for jerks at rest; note distribution (focal, multifocal, generalized), frequency, and amplitude
- Body habitus: Cachexia may suggest malignancy or chronic illness; hepatomegaly or jaundice suggests liver disease
- Skin findings: Jaundice (hepatic encephalopathy), uremic frost (renal failure), café-au-lait spots (neurofibromatosis), angiofibromas (tuberous sclerosis)
- Dysmorphic features: May suggest genetic syndrome, particularly in young patients with progressive myoclonic epilepsy
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever, hypothermia, or hyperthermia | Fever suggests infection or encephalitis; hyperthermia in serotonin syndrome or neuroleptic malignant syndrome |
| Heart Rate | Tachycardia, bradycardia, arrhythmia | Tachycardia in serotonin syndrome, sepsis, thyrotoxicosis; bradycardia in raised intracranial pressure |
| Blood Pressure | Hypertension, hypotension, lability | Labile blood pressure in autonomic instability (autoimmune encephalitis, serotonin syndrome); hypertensive encephalopathy |
| Respiratory Rate | Tachypnea, Kussmaul breathing, hypoventilation | Kussmaul breathing in metabolic acidosis; hypoventilation may cause hypercapnic encephalopathy |
| Oxygen Saturation | Hypoxemia | Acute hypoxia can cause myoclonus; chronic hypoxemia in lung disease |
Activation Maneuvers to Elicit Myoclonus
Myoclonus may not be present at rest and requires specific maneuvers to demonstrate. These tests also help characterize the type of myoclonus.
| Maneuver | Technique | What It Tests | Positive Finding Suggests |
|---|---|---|---|
| Postural hold | Arms outstretched, fingers spread, wrists dorsiflexed; hold for 30 seconds | Postural myoclonus and asterixis | Asterixis (flapping) indicates metabolic encephalopathy; postural jerks suggest cortical or essential myoclonus |
| Action testing | Finger-to-nose, pouring water, writing, drawing spiral | Action myoclonus | Action-induced jerks strongly suggest cortical myoclonus; typical of post-hypoxic and progressive myoclonic epilepsies |
| Finger tapping | Rapid alternating finger movements or thumb-finger opposition | Action myoclonus with fine motor tasks | Interference with rapid movements suggests cortical myoclonus |
| Tactile stimulus | Light touch or tap to hand, face, or affected body part | Stimulus-sensitive (reflex) myoclonus | Jerks triggered by touch indicate cortical reflex myoclonus |
| Auditory startle | Unexpected loud clap or noise behind patient | Startle myoclonus | Exaggerated startle suggests hyperekplexia or reticular reflex myoclonus; non-habituating response is pathological |
| Photic stimulation | Flickering light (or ask about sensitivity to sunlight, television) | Photosensitive myoclonus | Suggests epileptic myoclonus, particularly juvenile myoclonic epilepsy or progressive myoclonic epilepsy |
| Tendon tap | Standard reflex hammer tap to tendons | Reflex myoclonus | Spread of jerk beyond expected muscle group suggests cortical reflex myoclonus |
Neurological Examination
Mental Status
- Level of alertness: Encephalopathy suggests metabolic, toxic, or infectious cause
- Orientation and attention: Assess for delirium or fluctuating awareness
- Memory and cognition: Brief cognitive testing (Mini-Mental State Examination or Montreal Cognitive Assessment); impairment suggests neurodegenerative or autoimmune process
- Psychiatric symptoms: Anxiety, depression, personality change may indicate autoimmune encephalitis or Creutzfeldt-Jakob disease
Cranial Nerves
| Finding | Description | Associated Conditions |
|---|---|---|
| Opsoclonus | Chaotic, multidirectional saccadic eye movements | Opsoclonus-myoclonus syndrome (paraneoplastic or post-infectious) |
| Nystagmus | Rhythmic oscillation of eyes | Cerebellar disease, drug toxicity, Wernicke encephalopathy |
| Supranuclear gaze palsy | Impaired voluntary vertical gaze with preserved reflexive movements | Progressive supranuclear palsy, Niemann-Pick type C, Whipple disease |
| Facial myoclonus | Jerks of facial muscles | Cortical myoclonus, hemifacial spasm (peripheral), palatal myoclonus (brainstem) |
| Palatal movements | Rhythmic movements of soft palate | Palatal tremor (previously called palatal myoclonus); essential or symptomatic (brainstem/cerebellar lesion) |
| Hearing abnormality | Ear click with palatal movement | Essential palatal tremor (tensor veli palatini involvement) |
Motor Examination
- Tone: Rigidity suggests parkinsonism; spasticity suggests corticospinal tract involvement; hypotonia in cerebellar disease
- Strength: Weakness may indicate structural lesion, motor neuron disease, or peripheral neuropathy
- Other movement disorders: Look for dystonia (myoclonus-dystonia), tremor, chorea, parkinsonism—myoclonus often coexists with other movement disorders
Coordination and Gait
- Finger-to-nose and heel-to-shin: Cerebellar ataxia common in progressive myoclonic epilepsies and post-hypoxic myoclonus
- Rapid alternating movements: Assess for dysdiadochokinesia; also useful to elicit action myoclonus
- Gait: Wide-based ataxic gait in cerebellar involvement; festinating gait if parkinsonism present; jerks during walking suggest action myoclonus
- Romberg test: Positive with proprioceptive loss (may accompany some causes of myoclonus)
Reflexes
- Deep tendon reflexes: Hyperreflexia suggests upper motor neuron involvement; hyporeflexia in peripheral neuropathy
- Spread of reflexes: Reflex spread beyond expected muscle suggests cortical hyperexcitability
- Plantar responses: Extensor (Babinski sign) indicates corticospinal tract dysfunction
- Clonus: Sustained clonus indicates upper motor neuron lesion; can be confused with myoclonus
Sensory Examination
- Large fiber sensation: Vibration and proprioception; loss suggests posterior column involvement (vitamin B12 deficiency, spinocerebellar ataxia)
- Small fiber sensation: Pain and temperature; peripheral neuropathy may accompany some causes
- Cortical sensation: Stereognosis, graphesthesia; may be impaired with cortical lesions
Systemic Examination
Hepatic Assessment
Jaundice: Scleral icterus, skin yellowing
Hepatomegaly: Palpable liver edge
Spider angiomata: Suggest chronic liver disease
Palmar erythema: Associated with cirrhosis
Fetor hepaticus: Sweet, musty breath odor
Other Systems
Thyroid: Goiter, tremor, exophthalmos (thyrotoxicosis)
Lymphadenopathy: May suggest malignancy or infection
Splenomegaly: Storage disorders, hematologic malignancy
Kayser-Fleischer rings: Wilson disease (requires slit-lamp examination)
Expected Findings by Etiology
| Condition | Myoclonus Features | Associated Findings | Mental Status |
|---|---|---|---|
| Post-hypoxic (Lance-Adams) | Action-induced, multifocal, stimulus-sensitive | Cerebellar ataxia, sometimes dystonia | Usually preserved; may have subtle cognitive deficits |
| Juvenile myoclonic epilepsy | Generalized, morning predominance, action-induced | Usually normal examination between episodes | Normal |
| Progressive myoclonic epilepsy | Progressive, multifocal, action and stimulus-sensitive | Cerebellar ataxia, spasticity (varies by type) | Progressive cognitive decline |
| Creutzfeldt-Jakob disease | Stimulus-sensitive, often startle myoclonus | Cerebellar signs, pyramidal signs, visual symptoms | Rapidly progressive dementia |
| Metabolic encephalopathy | Asterixis (negative myoclonus), generalized jerks | Findings of underlying organ failure | Altered consciousness, fluctuating |
| Myoclonus-dystonia | Brief jerks, often neck and arms, alcohol-responsive | Dystonia (cervical, writer’s cramp) | Normal; may have psychiatric comorbidity |
| Essential myoclonus | Non-progressive, often postural or action-induced | Normal neurological examination | Normal |
| Functional myoclonus | Variable, distractible, incongruent pattern | May have other functional signs; examination otherwise normal | Normal; psychiatric comorbidity common |
Important Teaching Point
Normal examination between jerks is common! Many causes of myoclonus—including juvenile myoclonic epilepsy, essential myoclonus, myoclonus-dystonia, and drug-induced myoclonus—present with entirely normal neurological examination findings between episodes. A normal examination does not exclude significant pathology. Conversely, finding additional neurological abnormalities (ataxia, cognitive impairment, pyramidal signs) is highly informative and narrows the differential significantly toward symptomatic causes.
Distinguishing Myoclonus from Other Movement Disorders
| Movement | Key Features | How to Differentiate |
|---|---|---|
| Tremor | Rhythmic, oscillatory, relatively constant frequency | Myoclonus is arrhythmic and shock-like; tremor is sinusoidal and rhythmic |
| Chorea | Flowing, dance-like, random, longer duration | Myoclonus is briefer (less than 100 milliseconds); chorea has longer, flowing movements |
| Tics | Stereotyped, suppressible, preceded by urge | Tics are preceded by premonitory urge; myoclonus is not suppressible voluntarily |
| Dystonia | Sustained or twisting, slower, may have tremor | Dystonic movements are more sustained; “myoclonic dystonia” has both |
| Seizure (focal motor) | Rhythmic jerking, may spread (Jacksonian march) | Focal seizures are more rhythmic and evolve over seconds to minutes |
5. Differential Diagnosis
Systematic approach organized by probability, time course, and clinical features
Acute Myoclonus (Onset over hours to days)
Acute-onset myoclonus is often a medical emergency and requires urgent evaluation for treatable causes.
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON | Metabolic encephalopathy (uremia, hepatic failure, hypoglycemia, electrolyte disturbance) | Asterixis, altered consciousness, known organ failure, fluctuating course | Altered mental status, multiorgan dysfunction |
| COMMON | Drug toxicity or withdrawal (opioids, serotonergic agents, benzodiazepine withdrawal) | Recent medication change, polypharmacy, substance use history | Serotonin syndrome triad (altered mental status, autonomic instability, neuromuscular hyperactivity) |
| COMMON | Post-hypoxic myoclonus (acute phase) | History of cardiac arrest or respiratory failure within hours to days | Comatose patient, status myoclonus, poor prognosis if within 24 hours |
| LESS COMMON | Infectious encephalitis (viral, bacterial, prion) | Fever, headache, altered consciousness, seizures, focal deficits | Fever, meningismus, rapid progression |
| LESS COMMON | Autoimmune encephalitis (anti-NMDA receptor, anti-LGI1, anti-CASPR2) | Psychiatric symptoms, seizures, movement disorders, autonomic instability | Young patient with psychiatric presentation, faciobrachial dystonic seizures |
| UNCOMMON BUT SERIOUS | Creutzfeldt-Jakob disease | Rapidly progressive dementia, startle myoclonus, visual symptoms, ataxia | Progression over weeks, periodic sharp waves on electroencephalogram |
| UNCOMMON BUT SERIOUS | Nonconvulsive status epilepticus | Altered consciousness with subtle motor manifestations, prior seizure history | Prolonged post-ictal state, fluctuating awareness |
Subacute Myoclonus (Onset over weeks to months)
Step-by-Step Approach to Subacute Myoclonus:
- Step 1: Exclude ongoing toxic or metabolic cause — Review all medications, check comprehensive metabolic panel
- Step 2: Consider autoimmune and paraneoplastic causes — These are treatable if identified early
- Step 3: Evaluate for prion disease — Creutzfeldt-Jakob disease can present subacutely
- Step 4: Consider early neurodegenerative disease — May present before other features are apparent
| Probability | Condition | Key Distinguishing Features | Diagnostic Clue |
|---|---|---|---|
| COMMON | Autoimmune encephalitis | Subacute cognitive decline, psychiatric symptoms, seizures, movement disorders | Cerebrospinal fluid pleocytosis, autoantibody positivity, magnetic resonance imaging limbic changes |
| LESS COMMON | Paraneoplastic cerebellar degeneration with myoclonus | Subacute ataxia, myoclonus, known or occult malignancy | Anti-Yo, anti-Hu, anti-Ri antibodies; computed tomography chest/abdomen/pelvis |
| LESS COMMON | Opsoclonus-myoclonus syndrome | Chaotic eye movements, myoclonus, ataxia; paraneoplastic or post-infectious | Opsoclonus on examination; search for neuroblastoma (children) or lung/breast cancer (adults) |
| LESS COMMON | Creutzfeldt-Jakob disease | Rapidly progressive dementia, myoclonus, ataxia, visual symptoms | Periodic sharp wave complexes on electroencephalogram, diffusion-weighted imaging hyperintensities, elevated 14-3-3 protein |
| UNCOMMON | Subacute sclerosing panencephalitis | Cognitive decline, myoclonus, prior measles infection (often in childhood) | Periodic complexes on electroencephalogram, elevated cerebrospinal fluid measles antibodies |
| UNCOMMON | Hashimoto encephalopathy (steroid-responsive encephalopathy associated with autoimmune thyroiditis) | Encephalopathy, myoclonus, tremor, seizures; may have normal thyroid function | Elevated anti-thyroid peroxidase or anti-thyroglobulin antibodies; dramatic steroid response |
| UNCOMMON | Whipple disease | Oculomasticatory myorhythmia (pathognomonic), cognitive decline, gastrointestinal symptoms | Periodic acid-Schiff positive macrophages on small bowel biopsy; polymerase chain reaction for Tropheryma whipplei |
Chronic Myoclonus (Present for months to years)
| Category | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON — Epileptic | Juvenile myoclonic epilepsy | Most common cause of epileptic myoclonus | Onset in adolescence, morning jerks, generalized tonic-clonic seizures, sleep deprivation trigger, normal cognition |
| COMMON — Post-hypoxic | Lance-Adams syndrome (chronic post-hypoxic myoclonus) | Common in cardiac arrest survivors | History of hypoxic event, action-induced, stimulus-sensitive, often with ataxia, preserved cognition |
| COMMON — Essential | Essential myoclonus | 5-10% of myoclonus cases | Isolated myoclonus, no other neurological abnormalities, often familial, non-progressive |
| COMMON — Functional | Functional (psychogenic) myoclonus | Up to 10% of movement disorder clinic referrals | Variable, distractible, entrainable, incongruent pattern, often axial, psychological stressors |
| LESS COMMON — Genetic | Myoclonus-dystonia syndrome (SGCE mutation) | Rare but important to recognize | Young onset, alcohol-responsive, associated cervical or arm dystonia, autosomal dominant with maternal imprinting |
| LESS COMMON — Neurodegenerative | Corticobasal degeneration | Rare | Asymmetric parkinsonism, cortical sensory loss, apraxia, alien limb, stimulus-sensitive myoclonus |
| LESS COMMON — Neurodegenerative | Dementia with Lewy bodies | Myoclonus in up to 20% | Fluctuating cognition, visual hallucinations, parkinsonism, rapid eye movement sleep behavior disorder |
| LESS COMMON — Neurodegenerative | Alzheimer disease (advanced) | Myoclonus in 5-10%, more in familial forms | Progressive dementia, myoclonus typically late in disease course |
| UNCOMMON — Progressive myoclonic epilepsy | Unverricht-Lundborg disease | Most common progressive myoclonic epilepsy in Western countries | Onset 6-15 years, stimulus-sensitive myoclonus, generalized seizures, ataxia, slow cognitive decline, CSTB gene mutation |
| UNCOMMON — Progressive myoclonic epilepsy | Lafora disease | Rare | Onset 12-17 years, visual seizures, rapidly progressive dementia, Lafora bodies on skin biopsy |
| UNCOMMON — Progressive myoclonic epilepsy | Neuronal ceroid lipofuscinoses | Rare | Variable age of onset, visual loss, cognitive decline, seizures, myoclonus |
| UNCOMMON — Progressive myoclonic epilepsy | Sialidosis type 1 (cherry-red spot myoclonus syndrome) | Rare | Cherry-red spot on fundoscopy, action myoclonus, ataxia, normal cognition initially |
Anatomical Approach to Differential Diagnosis
Cortical Origin
Post-hypoxic myoclonus (Lance-Adams)
Progressive myoclonic epilepsies
Corticobasal degeneration
Alzheimer disease
Creutzfeldt-Jakob disease
Celiac disease-associated
Subcortical Origin (Brainstem/Basal Ganglia)
Reticular reflex myoclonus
Hyperekplexia (startle disease)
Palatal tremor (palatal myoclonus)
Progressive supranuclear palsy
Multiple system atrophy
Opsoclonus-myoclonus syndrome
Spinal Origin
Propriospinal myoclonus
Segmental spinal myoclonus
Spinal cord lesions (tumor, demyelination)
Post-infectious myelitis
Functional (psychogenic) myoclonus
Peripheral Origin
Hemifacial spasm
Peripheral nerve injury
Radiculopathy
Post-radiation plexopathy
Drug-Induced Myoclonus
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Opioids (especially morphine, hydromorphone) | Accumulation of neuroexcitatory metabolites (morphine-3-glucuronide); worse with renal impairment | Multifocal, often nocturnal, may be severe; associated with hyperalgesia | Days to weeks; consider opioid rotation |
| Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors | Serotonergic excess, particularly with drug combinations (serotonin syndrome) | Generalized, often with tremor, hyperreflexia, autonomic instability | 24-72 hours for mild cases; may be prolonged with fluoxetine |
| Tricyclic antidepressants | Serotonergic and anticholinergic effects; toxicity in overdose | Often part of toxicity syndrome with seizures, cardiac effects | Days; depends on elimination half-life |
| Lithium | Neurotoxicity, particularly at higher levels; causes asterixis and myoclonus | Asterixis common; myoclonus with toxicity; may have tremor, ataxia | Days to weeks; correlates with level normalization |
| Levodopa and dopamine agonists | Dopaminergic stimulation in susceptible patients | Often occurs with dyskinesias in advanced Parkinson disease | Usually resolves with dose reduction |
| Antipsychotics | Dopamine blockade; tardive myoclonus with chronic use | May be part of tardive syndrome; neuroleptic malignant syndrome causes myoclonus | Tardive forms may persist; acute improves with drug cessation |
| Anticonvulsants (carbamazepine, phenytoin, gabapentin, pregabalin) | Paradoxical worsening of myoclonus; phenytoin particularly problematic | May worsen myoclonus in progressive myoclonic epilepsies and juvenile myoclonic epilepsy | Days to weeks after discontinuation |
| Antibiotics (quinolones, cephalosporins, penicillins, carbapenems) | GABA-A receptor antagonism; worse with renal impairment and blood-brain barrier disruption | Often in critically ill patients; may be part of encephalopathy | Days after discontinuation and renal clearance |
| Bismuth | Neurotoxicity with chronic ingestion (bismuth encephalopathy) | Myoclonus with encephalopathy, ataxia; history of bismuth-containing antacid use | Weeks to months after cessation |
| Contrast agents (intrathecal) | Direct neurotoxicity | Occurs after myelography or intrathecal procedures | Usually self-limited over days |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Morning jerks in a teenager with generalized seizures | Juvenile myoclonic epilepsy | Electroencephalogram; avoid phenytoin and carbamazepine |
| Action myoclonus after cardiac arrest with preserved cognition | Lance-Adams syndrome (chronic post-hypoxic myoclonus) | Trial of levetiracetam or valproate |
| Asterixis with altered consciousness | Metabolic encephalopathy (hepatic, uremic) | Check ammonia, liver function tests, renal function, electrolytes |
| Myoclonus dramatically improved by alcohol | Myoclonus-dystonia syndrome | Examine for dystonia; consider SGCE genetic testing |
| Rapidly progressive dementia with startle myoclonus | Creutzfeldt-Jakob disease | Magnetic resonance imaging with diffusion-weighted imaging, electroencephalogram, cerebrospinal fluid 14-3-3 and real-time quaking-induced conversion |
| Opsoclonus with myoclonus and ataxia | Opsoclonus-myoclonus syndrome (paraneoplastic or post-infectious) | Computed tomography chest/abdomen/pelvis; paraneoplastic antibody panel |
| Myoclonus with psychiatric symptoms in young adult | Anti-NMDA receptor encephalitis | Cerebrospinal fluid anti-NMDA receptor antibodies; pelvic imaging for ovarian teratoma |
| Rhythmic palatal movements with ear clicking | Essential palatal tremor | Usually no workup needed; magnetic resonance imaging brainstem if symptomatic type suspected |
| Axial jerks worse when supine, variable pattern | Propriospinal myoclonus (often functional) | Neurophysiology to assess; evaluate for functional features |
| Exaggerated startle that does not habituate | Hyperekplexia (startle disease) | Consider GLRA1 genetic testing; trial of clonazepam |
| Myoclonus in patient on multiple serotonergic drugs | Serotonin syndrome | Stop serotonergic agents; supportive care; cyproheptadine if severe |
| Cherry-red spot on fundoscopy with action myoclonus | Sialidosis type 1 | Alpha-neuraminidase enzyme activity; genetic testing |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Baseline Investigations for All Patients with Unexplained Myoclonus
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Screen for infection, anemia, hematologic malignancy | Leukocytosis, anemia, thrombocytopenia | Anemia may suggest chronic disease; pancytopenia in some storage disorders |
| Comprehensive metabolic panel | Identify metabolic causes | Elevated creatinine (uremia), elevated liver enzymes/bilirubin (hepatic), glucose abnormalities | Uremia and hepatic failure are common reversible causes |
| Calcium, magnesium, phosphate | Electrolyte abnormalities causing myoclonus | Hypocalcemia, hypomagnesemia, hypophosphatemia | Hypocalcemia causes tetany and myoclonic jerks |
| Ammonia | Hepatic encephalopathy | Elevated ammonia level | Must be collected and processed correctly (on ice, rapid analysis) |
| Thyroid function tests | Thyroid dysfunction | Thyrotoxicosis (tremor, myoclonus), hypothyroidism | Also order anti-thyroid peroxidase antibodies if suspecting Hashimoto encephalopathy |
| Drug and toxicology screen | Identify drug-induced or toxic causes | Serotonergic drugs, opioids, lithium level if applicable | Review complete medication list including over-the-counter and supplements |
| Electroencephalogram | Characterize myoclonus, identify epileptic activity | Generalized spike-wave (epileptic), periodic sharp waves (Creutzfeldt-Jakob disease), focal spikes | Routine electroencephalogram may be normal; video-electroencephalogram with back-averaging more sensitive |
| Magnetic resonance imaging of the brain | Structural lesions, neurodegeneration, encephalitis | Diffusion-weighted imaging hyperintensities (Creutzfeldt-Jakob disease), limbic changes (autoimmune), cerebellar atrophy | Include diffusion-weighted imaging sequences; may be normal in many causes |
Targeted Investigations by Suspected Etiology
If Suspecting Epileptic Myoclonus
First-Line Tests
- Routine electroencephalogram: Generalized 4-6 Hz polyspike-wave in juvenile myoclonic epilepsy; may be normal between episodes
- Sleep-deprived electroencephalogram: Increases sensitivity for detecting epileptiform activity
- Magnetic resonance imaging brain: Typically normal in juvenile myoclonic epilepsy; may show abnormalities in symptomatic epilepsies
Second-Line Tests
- Video-electroencephalogram monitoring: Captures events for correlation with electroencephalogram; essential for characterization
- Genetic testing: Epilepsy gene panel if familial or if progressive myoclonic epilepsy suspected
- Photic stimulation during electroencephalogram: Photosensitivity supports diagnosis of juvenile myoclonic epilepsy
If Suspecting Progressive Myoclonic Epilepsy
First-Line Tests
- Electroencephalogram: Background slowing, generalized spike-wave, photosensitivity
- Magnetic resonance imaging brain: Cerebellar atrophy common; specific patterns in some disorders
- Ophthalmologic examination: Cherry-red spot (sialidosis), retinal degeneration (neuronal ceroid lipofuscinosis)
Second-Line Tests
- Genetic testing: CSTB (Unverricht-Lundborg), EPM2A/EPM2B (Lafora), specific genes by clinical suspicion
- Skin or axillary sweat gland biopsy: Lafora bodies (Lafora disease)
- Enzyme assays: Alpha-neuraminidase (sialidosis), specific enzyme deficiencies
- Bone marrow or tissue biopsy: Storage material in some conditions
If Suspecting Autoimmune or Paraneoplastic Cause
First-Line Tests
- Lumbar puncture: Cerebrospinal fluid pleocytosis, elevated protein, oligoclonal bands
- Autoimmune encephalitis antibody panel: Anti-NMDA receptor, anti-LGI1, anti-CASPR2, anti-GABA-B receptor, anti-AMPA receptor (serum and cerebrospinal fluid)
- Paraneoplastic antibody panel: Anti-Hu, anti-Yo, anti-Ri, anti-amphiphysin, anti-CV2/CRMP5
Second-Line Tests
- Computed tomography chest, abdomen, pelvis: Occult malignancy search
- Positron emission tomography-computed tomography: If initial imaging negative but high clinical suspicion
- Pelvic ultrasound or magnetic resonance imaging: Ovarian teratoma in anti-NMDA receptor encephalitis
- Testicular ultrasound: If appropriate
If Suspecting Creutzfeldt-Jakob Disease
First-Line Tests
- Magnetic resonance imaging brain with diffusion-weighted imaging: “Cortical ribboning” and/or basal ganglia hyperintensity on diffusion-weighted imaging; sensitivity 90-95%
- Electroencephalogram: Periodic sharp wave complexes (present in approximately 65%); may be absent early
- Cerebrospinal fluid analysis: 14-3-3 protein (sensitivity 85-95%), elevated tau, neuron-specific enolase
Second-Line Tests
- Real-time quaking-induced conversion assay: Cerebrospinal fluid test with sensitivity greater than 90% and specificity approaching 100%
- PRNP gene sequencing: Identifies familial forms; codon 129 polymorphism affects phenotype
- Brain biopsy: Rarely needed given non-invasive test accuracy; considered in atypical cases
If Suspecting Myoclonus-Dystonia Syndrome
First-Line Tests
- Clinical examination: Look for subtle dystonia (cervical, writer’s cramp); assess alcohol response (history)
- Family history: Autosomal dominant with maternal imprinting (maternally inherited mutations are silenced)
- Magnetic resonance imaging brain: Typically normal; excludes structural causes
Second-Line Tests
- SGCE gene testing: Epsilon-sarcoglycan gene mutations; positive in approximately 30-50% of clinically suspected cases
- Dystonia gene panel: Consider if SGCE negative; other genes can cause similar phenotype
If Suspecting Functional (Psychogenic) Myoclonus
Clinical Features Supporting Diagnosis
- Variability: Amplitude, frequency, and distribution change spontaneously or with attention
- Distractibility: Myoclonus improves when patient is distracted
- Entrainment: Jerks can be entrained to externally paced rhythm
- Suggestibility: Symptoms change with suggestion (for example, with placebo)
- Bereitschaftspotential: Readiness potential on electroencephalogram back-averaging preceding movement (indicates voluntary origin)
Investigations
- Video-electroencephalogram with back-averaging: Presence of Bereitschaftspotential (slow negative shift preceding movement by 1-2 seconds) supports functional etiology
- Electromyography: Variable electromyography burst duration; inconsistent recruitment pattern
- Basic workup: Normal baseline tests support (but do not confirm) functional diagnosis
- Psychiatric evaluation: Assess for anxiety, depression, prior trauma, secondary gain
Neurophysiological Studies: The Key to Localization
Electroencephalogram and Electromyography with Back-Averaging
This is the gold standard for localizing the generator of myoclonus. The technique involves recording many myoclonic jerks and averaging the electroencephalogram signal time-locked to the electromyography burst onset.
- Cortical myoclonus: Cortical spike precedes electromyography burst by 20-40 milliseconds (time for corticospinal conduction)
- Subcortical (reticular) myoclonus: No cortical correlate, or electroencephalogram change follows the electromyography burst
- Spinal myoclonus: No cortical correlate; electromyography shows segmental spread pattern
- Functional myoclonus: Bereitschaftspotential (slow negative shift) precedes movement by 1-2 seconds
| Neurophysiology Finding | Interpretation | Associated Conditions |
|---|---|---|
| Giant somatosensory evoked potentials (P25-N33 greater than 10 microvolts) | Cortical hyperexcitability | Cortical myoclonus (post-hypoxic, progressive myoclonic epilepsy, corticobasal degeneration) |
| Enhanced C-reflex (long-latency reflex) | Hyperexcitable transcortical reflex loop | Cortical reflex myoclonus |
| Electroencephalogram spike preceding electromyography by 20-40 milliseconds | Cortical generator | Cortical myoclonus of any etiology |
| Short electromyography burst duration (less than 50 milliseconds) with no cortical correlate | Subcortical (brainstem) generator | Reticular reflex myoclonus, hyperekplexia |
| Bereitschaftspotential preceding movement | Voluntary movement preparation | Functional (psychogenic) myoclonus |
| Periodic sharp wave complexes on electroencephalogram | Diffuse cortical dysfunction | Creutzfeldt-Jakob disease (1 Hz), subacute sclerosing panencephalitis (longer periodicity) |
Empiric Treatment Trials as Diagnostic Tools
When the Diagnosis Remains Unclear
In some cases, response to empiric treatment can provide diagnostic information. However, this approach should complement rather than replace appropriate investigations.
- Alcohol trial: Dramatic improvement with small amounts of alcohol strongly suggests myoclonus-dystonia syndrome (SGCE-related)
- Clonazepam trial: Response to low-dose clonazepam (0.5-1 mg) supports diagnosis of essential myoclonus or cortical myoclonus; helps guide chronic therapy
- Levetiracetam trial: Effective in cortical myoclonus; lack of response may suggest subcortical or spinal generator
- Corticosteroid trial: If autoimmune encephalopathy suspected (Hashimoto encephalopathy); dramatic response supports diagnosis
- Placebo response: Marked improvement with placebo or suggestion supports functional myoclonus
Summary: Investigation Pathway by Clinical Scenario
| Clinical Scenario | Priority Investigations | Key Findings to Seek |
|---|---|---|
| Acute onset with encephalopathy | Metabolic panel, ammonia, toxicology, electroencephalogram, magnetic resonance imaging, lumbar puncture | Reversible metabolic cause, nonconvulsive status, encephalitis |
| Subacute progressive with cognitive decline | Magnetic resonance imaging diffusion-weighted imaging, electroencephalogram, cerebrospinal fluid (14-3-3, real-time quaking-induced conversion, autoimmune panel) | Creutzfeldt-Jakob disease, autoimmune encephalitis |
| Young patient with morning jerks and seizures | Electroencephalogram (sleep-deprived), routine magnetic resonance imaging | Polyspike-wave, photosensitivity (juvenile myoclonic epilepsy) |
| Chronic action myoclonus after cardiac arrest | Electroencephalogram with back-averaging, somatosensory evoked potentials | Cortical origin, giant somatosensory evoked potentials (Lance-Adams) |
| Myoclonus with dystonia, alcohol-responsive | SGCE genetic testing, routine magnetic resonance imaging | SGCE mutation (myoclonus-dystonia) |
| Variable axial jerks, distractible | Video-electroencephalogram with back-averaging, psychiatric evaluation | Bereitschaftspotential, inconsistent pattern (functional) |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways for myoclonus
Step 1: Is This Urgent?
The first priority is to identify patients requiring immediate intervention. Myoclonus can be a sign of life-threatening conditions that demand urgent workup and treatment.
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Myoclonus with altered consciousness after cardiac arrest (within 72 hours) | EMERGENT | Continue intensive care; electroencephalogram to rule out nonconvulsive status epilepticus; somatosensory evoked potentials for prognostication; avoid premature withdrawal of care |
| Myoclonus with fever, headache, and confusion | EMERGENT | Lumbar puncture after imaging; empiric acyclovir and antibiotics; urgent magnetic resonance imaging; autoimmune encephalitis workup |
| Myoclonus with autonomic instability and recent serotonergic drug use | EMERGENT | Stop all serotonergic agents immediately; supportive care; cyproheptadine if severe; intensive care unit admission if unstable |
| Status myoclonus (continuous or near-continuous jerks) | EMERGENT | Intravenous benzodiazepines; electroencephalogram monitoring; identify and treat underlying cause; intensive care unit admission |
| Myoclonus with rapidly progressive dementia (weeks) | URGENT | Urgent magnetic resonance imaging with diffusion-weighted imaging; electroencephalogram; lumbar puncture for Creutzfeldt-Jakob disease and autoimmune markers |
| New myoclonus in patient with known malignancy | URGENT | Paraneoplastic antibody panel; cerebrospinal fluid analysis; imaging for metastases; consider empiric immunotherapy if high suspicion |
| Myoclonus with asterixis and known liver or kidney disease | URGENT | Metabolic workup; ammonia level; assess for precipitants; optimize treatment of organ failure |
| Chronic stable myoclonus affecting function | ROUTINE | Outpatient neurology referral; systematic workup; trial of symptomatic therapy |
| Isolated hypnic jerks or physiological myoclonus | ROUTINE | Reassurance; no workup needed if typical presentation; sleep hygiene counseling |
Step 2: Classify by Time Course
Acute (Hours to Days)
Proceed to Algorithm A
Focus on: Metabolic, toxic, infectious, post-hypoxic causes
Setting: Usually inpatient/emergency
Subacute (Weeks to Months)
Proceed to Algorithm B
Focus on: Autoimmune, paraneoplastic, prion disease, early neurodegenerative
Setting: Urgent outpatient or inpatient
Chronic (Months to Years)
Proceed to Algorithm C
Focus on: Epileptic, essential, genetic, post-hypoxic (Lance-Adams), functional
Setting: Outpatient neurology
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Myoclonus
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Altered consciousness + asterixis + known liver disease | Hepatic encephalopathy | Check ammonia; lactulose; identify precipitant (infection, gastrointestinal bleeding, medications) |
| Altered consciousness + asterixis + elevated creatinine | Uremic encephalopathy | Urgent dialysis; correct electrolytes; review medications for accumulation |
| Myoclonus within 24-72 hours of cardiac arrest, patient comatose | Post-hypoxic myoclonus (acute, poor prognosis indicator) | Continuous electroencephalogram; somatosensory evoked potentials at 72 hours; multimodal prognostication |
| Myoclonus + hyperthermia + rigidity + recent antipsychotic use | Neuroleptic malignant syndrome | Stop antipsychotic; supportive care; dantrolene or bromocriptine; intensive care unit |
| Myoclonus + hyperthermia + hyperreflexia + serotonergic drugs | Serotonin syndrome | Stop all serotonergic agents; benzodiazepines; cyproheptadine; cooling if hyperthermic |
| Myoclonus appearing after stopping benzodiazepines or alcohol | Withdrawal syndrome | Benzodiazepine replacement; gradual taper; monitor for seizures |
| Myoclonus + fever + headache + confusion | Encephalitis (viral, autoimmune) | Lumbar puncture; empiric acyclovir; magnetic resonance imaging; autoimmune panel |
Algorithm B: Subacute Myoclonus
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Young adult + psychiatric symptoms + seizures + movement disorder | Anti-NMDA receptor encephalitis | Cerebrospinal fluid and serum anti-NMDA receptor antibodies; pelvic imaging for teratoma; early immunotherapy |
| Faciobrachial dystonic seizures + hyponatremia | Anti-LGI1 encephalitis | Anti-LGI1 antibodies; magnetic resonance imaging (mesial temporal changes); immunotherapy |
| Rapidly progressive dementia + startle myoclonus + ataxia | Creutzfeldt-Jakob disease | Magnetic resonance imaging diffusion-weighted imaging; electroencephalogram; cerebrospinal fluid real-time quaking-induced conversion |
| Opsoclonus + myoclonus + ataxia | Opsoclonus-myoclonus syndrome | Computed tomography chest/abdomen/pelvis; paraneoplastic panel; immunotherapy |
| Encephalopathy + myoclonus + elevated anti-thyroid antibodies | Hashimoto encephalopathy | Trial of high-dose corticosteroids; dramatic response supports diagnosis |
| Cognitive decline + oculomasticatory myorhythmia + gastrointestinal symptoms | Whipple disease | Small bowel biopsy; polymerase chain reaction for Tropheryma whipplei; prolonged antibiotics |
Algorithm C: Chronic Myoclonus
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Morning jerks + generalized tonic-clonic seizures + teenage onset | Juvenile myoclonic epilepsy | Electroencephalogram; valproate or levetiracetam; avoid carbamazepine/phenytoin; lifelong treatment |
| Action myoclonus + ataxia + history of cardiac arrest | Lance-Adams syndrome | Trial of levetiracetam, valproate, or clonazepam; often requires polytherapy; rehabilitation |
| Myoclonus + dystonia + alcohol responsiveness | Myoclonus-dystonia syndrome | SGCE genetic testing; clonazepam; consider deep brain stimulation if severe |
| Isolated myoclonus + normal examination + non-progressive | Essential myoclonus | Reassurance; clonazepam or levetiracetam if functionally limiting |
| Progressive myoclonus + seizures + ataxia + cognitive decline in child/adolescent | Progressive myoclonic epilepsy | Genetic testing (CSTB, EPM2A, others); ophthalmologic examination; multidisciplinary care |
| Variable jerks + distractible + inconsistent pattern + psychological stressors | Functional myoclonus | Video-electroencephalogram with back-averaging; positive diagnosis approach; multidisciplinary rehabilitation |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient on opioids develops myoclonus | Reduce opioid dose or rotate to different opioid (fentanyl, methadone have less accumulation) | Consider adding clonazepam 0.5 mg twice daily if rotation not possible |
| Myoclonus worsens after starting anticonvulsant | Stop the offending drug (especially carbamazepine, phenytoin, gabapentin) | Switch to myoclonus-appropriate agent (levetiracetam, valproate, clonazepam) |
| Patient requests alcohol for myoclonus relief | Recognize this as potential myoclonus-dystonia syndrome | SGCE genetic testing; clonazepam often provides similar relief without alcohol risks |
| Post-cardiac arrest patient has myoclonus but is awakening | Do not use myoclonus alone for poor prognosis; continue supportive care | Treat symptomatically with levetiracetam; many patients with Lance-Adams syndrome have good outcomes |
| First-line agent (levetiracetam) ineffective | Add second agent rather than switching (valproate or clonazepam) | Consider piracetam as add-on; neurophysiology to confirm cortical origin |
| Suspected functional myoclonus | Perform positive diagnostic tests (look for Bereitschaftspotential, variability, entrainment) | Explain diagnosis positively; refer for specialized physiotherapy; address psychological factors |
| Creutzfeldt-Jakob disease confirmed | Provide prognosis sensitively; symptom management focus | Clonazepam or valproate for myoclonus; palliative care involvement; infection control for procedures |
| Autoimmune encephalitis suspected but antibody-negative | Consider empiric immunotherapy if clinical suspicion high | Repeat testing in 2-4 weeks; some antibodies may be present only in cerebrospinal fluid |
Troubleshooting Refractory Myoclonus
When Myoclonus Does Not Respond to Treatment, Ask These Questions
- Is the diagnosis correct? Reconsider the underlying etiology; could this be functional myoclonus?
- Is the generator correctly identified? Cortical myoclonus responds differently than brainstem or spinal myoclonus
- Are there multiple overlapping causes? Drug-induced myoclonus may coexist with underlying neurological disease
- Has the underlying cause been adequately treated? Autoimmune conditions may need more aggressive immunotherapy
- Is the medication reaching adequate levels? Check valproate level; ensure clonazepam dose is sufficient
- Is medication compliance adequate? Valproate and clonazepam require consistent dosing
- Are there drug interactions? Some combinations reduce efficacy
- Would combination therapy help? Polytherapy is often necessary, especially in post-hypoxic myoclonus
- Are there modifiable exacerbating factors? Sleep deprivation, caffeine, stress, and medications can worsen myoclonus
When to Refer to a Movement Disorder Specialist
Consider specialist referral when:
- Diagnosis remains unclear after initial workup
- Myoclonus is refractory to first-line treatments
- Progressive myoclonic epilepsy is suspected
- Genetic testing and counseling are needed
- Neurophysiological studies (electroencephalogram-electromyography back-averaging) are required for localization
- Deep brain stimulation is being considered for severe myoclonus-dystonia
- Functional myoclonus is suspected and specialized rehabilitation is needed
- Complex medication management is required (polytherapy)
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Asterixis is negative myoclonus: The “flapping tremor” of metabolic encephalopathy is actually intermittent lapses in muscle tone, not active muscle contractions. Its presence should prompt immediate investigation for hepatic, uremic, or hypercapnic encephalopathy.
Alcohol responsiveness is a diagnostic clue: Dramatic improvement with small amounts of alcohol strongly suggests myoclonus-dystonia syndrome (SGCE mutation). Clonazepam often provides similar benefit without the risks of alcohol use.
Morning predominance suggests juvenile myoclonic epilepsy: Myoclonic jerks occurring mainly in the morning after waking, especially with a history of generalized tonic-clonic seizures and sleep deprivation sensitivity, is classic for juvenile myoclonic epilepsy—the most common cause of epileptic myoclonus.
Post-hypoxic myoclonus has two very different contexts: Myoclonus within 24-72 hours of cardiac arrest in a comatose patient suggests severe brain injury, but Lance-Adams syndrome (myoclonus in an awakened survivor) can occur with preserved cognition and reasonable functional outcomes.
Action myoclonus points to cortical origin: Myoclonus that worsens with voluntary movement, especially fine motor tasks, typically arises from the sensorimotor cortex and responds best to levetiracetam, valproate, and piracetam.
Electroencephalogram-electromyography back-averaging is the gold standard: This neurophysiological technique definitively identifies the generator of myoclonus by demonstrating whether a cortical spike precedes the muscle jerk, guiding both diagnosis and treatment selection.
Functional myoclonus is common and treatable: Up to 10% of patients referred to movement disorder clinics have functional (psychogenic) myoclonus. Key features include variability, distractibility, and Bereitschaftspotential on electroencephalogram back-averaging. Positive diagnosis and specialized physiotherapy lead to good outcomes.
Polytherapy is often necessary: Unlike many neurological conditions, myoclonus frequently requires combination therapy. In post-hypoxic myoclonus particularly, using levetiracetam plus valproate plus clonazepam together is often more effective than any single agent.
Critical Pitfalls to Avoid
Using phenytoin or carbamazepine for myoclonic epilepsy: These sodium channel blockers can paradoxically worsen myoclonus, particularly in juvenile myoclonic epilepsy and progressive myoclonic epilepsies. Always use valproate, levetiracetam, or clonazepam instead.
Pronouncing poor prognosis based on early post-hypoxic myoclonus alone: Myoclonus status within 24 hours of cardiac arrest was historically considered a poor prognostic sign, but in the era of therapeutic hypothermia, this is no longer reliable. Use multimodal prognostication at 72+ hours.
Missing serotonin syndrome: The combination of myoclonus, hyperthermia, and hyperreflexia in a patient on serotonergic medications (especially drug combinations) is serotonin syndrome until proven otherwise. This is a medical emergency requiring immediate drug cessation.
Attributing myoclonus to anxiety without proper evaluation: While anxiety can worsen myoclonus, new-onset myoclonic jerks require neurological evaluation. Do not dismiss as “stress” without ruling out metabolic, toxic, autoimmune, and structural causes.
Failing to consider autoimmune encephalitis in subacute presentations: A young patient with new psychiatric symptoms, seizures, and movement disorders may have anti-NMDA receptor encephalitis or another autoimmune encephalitis. Early immunotherapy can be life-saving.
Overlooking opioid-induced myoclonus: Opioids, especially morphine and hydromorphone in patients with renal impairment, commonly cause myoclonus due to neuroexcitatory metabolite accumulation. Opioid rotation to fentanyl or methadone often resolves the problem.
Diagnosing functional myoclonus by exclusion: Functional myoclonus should be diagnosed by positive clinical and neurophysiological features (variability, distractibility, Bereitschaftspotential), not simply by ruling out organic causes. A positive diagnosis approach leads to better patient outcomes.
Forgetting to examine the eyes in opsoclonus-myoclonus: Opsoclonus (chaotic multidirectional saccades) can be subtle and easily missed if not specifically assessed. This finding with myoclonus requires urgent paraneoplastic workup and malignancy screening.
Key Takeaways
- Myoclonus is classified by etiology (physiological, essential, epileptic, symptomatic), anatomical origin (cortical, subcortical, spinal, peripheral), and time course (acute, subacute, chronic)—each dimension guides investigation and treatment
- Acute myoclonus with altered consciousness demands urgent evaluation for metabolic encephalopathy, drug toxicity, infection, and hypoxic injury
- The “Big Three” questions for any myoclonus patient: Where is it coming from? What is causing it? How disabling is it?
- Asterixis (negative myoclonus) is the hallmark of metabolic encephalopathy—its presence should trigger immediate metabolic workup
- Action myoclonus that worsens with movement suggests cortical origin and responds to levetiracetam, valproate, and piracetam
- Juvenile myoclonic epilepsy presents with morning jerks and is the most common epileptic myoclonus—avoid phenytoin and carbamazepine
- Lance-Adams syndrome (chronic post-hypoxic myoclonus) can occur with preserved cognition; do not confuse with acute post-arrest myoclonus
- Dramatic alcohol responsiveness suggests myoclonus-dystonia syndrome—consider SGCE genetic testing
- Rapidly progressive dementia with myoclonus raises concern for Creutzfeldt-Jakob disease—obtain magnetic resonance imaging diffusion-weighted imaging, electroencephalogram, and cerebrospinal fluid real-time quaking-induced conversion
- Subacute myoclonus with psychiatric features in a young adult warrants autoimmune encephalitis workup—early treatment improves outcomes
- Electroencephalogram-electromyography back-averaging is the definitive test for localizing the myoclonus generator
- Functional myoclonus is common; diagnose by positive features (variability, distractibility, Bereitschaftspotential), not by exclusion
- Polytherapy is often required—combining levetiracetam, valproate, and clonazepam is frequently more effective than monotherapy
- Always review medications—many drugs cause myoclonus, and some anticonvulsants can paradoxically worsen it
Quick Reference Algorithm
Systematic Approach to Myoclonus:
- Identify urgency: Is the patient encephalopathic, post-cardiac arrest, or showing signs of serotonin syndrome or neuroleptic malignant syndrome? If yes, treat as emergency
- Classify by time course: Acute (hours-days), subacute (weeks-months), or chronic (months-years)—this determines the differential diagnosis
- Characterize the myoclonus: Distribution, timing, action versus rest, stimulus sensitivity—these features suggest the anatomical origin
- Review medications: Stop or rotate any drug that could cause myoclonus; avoid phenytoin and carbamazepine
- Perform baseline workup: Metabolic panel, ammonia, electroencephalogram, and magnetic resonance imaging brain for unexplained cases
- Target investigations to clinical suspicion: Autoimmune panel for subacute encephalopathy, genetic testing for familial cases, neurophysiology for localization
- Initiate treatment based on generator: Levetiracetam and valproate for cortical myoclonus, clonazepam for most types, combination therapy often needed
- Consider functional etiology: If features suggest functional myoclonus, pursue positive diagnosis with video-electroencephalogram back-averaging
- Refer to specialist if refractory: Movement disorder neurologist for complex cases, neurophysiology, genetic counseling, or consideration of deep brain stimulation